5 Stocks Under Wall Street’s Radar: Lpath Inc. (NASDAQ:LPTN), Navios Maritime Midstream Partners (NYSE:NAP), ONE Gas (NYSE:OGS), Anacor Pharmaceuticals (NASDAQ:ANAC), Iteris (NYSEMKT:ITI)

Lpath Inc. (NASDAQ:LPTN) belongs to Healthcare sector. Its weekly performance is 2.47%. On last trading day company shares ended up $0.28. Lpath Inc. (NASDAQ:LPTN) distance from 50-day simple moving average (SMA50) is -63.92%. On June 16, 2015, the Board of Directors of Lpath, Inc. (NASDAQ:LPTN) granted stock options pursuant to the Company’s Amended and Restated 2005 Equity Incentive Plan to Gary Atkinson, Gary Woodnutt, Ph.D., and Dario Paggiarino, M.D., each of whom is a named executive officer of the Company. The Board granted the Stock Options as a retention tool for these named executive officers. Each of the Stock Options are exercisable to purchase 150,000 shares of the Company’s common stock at a purchase price of $0.28 per share, the closing price of the Company’s common stock on the NASDAQ Capital Market on June 15, 2015.

Navios Maritime Midstream Partners L.P. (NYSE:NAP) shares increased 6.35% in last trading session and ended the day at $16.24. NAP Gross Margin is 96.90% and its return on assets is 2.10%. Navios Maritime Midstream Partners L.P. (NYSE:NAP) quarterly performance is 10.94%. Analysts at Citigroup Inc. hoisted their price objective on shares of Navios Maritime Midstream Partners (NYSE:NAP) from $18.00 to $19.00 in a research report issued to clients and investors on Thursday. The firm currently has a “buy” rating on the stock. Citigroup Inc.’s target price would suggest a potential upside of 11.63% from the stock’s previous close.

On 10 July, ONE Gas, Inc. Common Stock (NYSE:OGS) shares fell -0.96% and was closed at $43.48. OGS EPS growth in last 5 year was 6.10%. ONE Gas, Inc. Common Stock (NYSE:OGS) year to date (YTD) performance is 7.02%. ONE Gas, Inc. (NYSE:OGS) announced that its Oklahoma Natural Gas division filed a request with the Oklahoma Corporation Commission (OCC) for an increase in base rates, reflecting system investments and operating costs necessary to maintain the safety and reliability of its natural gas distribution system.

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) ended the last trading day at $84.61. Company weekly volatility is calculated as 4.96% and price to cash ratio as 21.16. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) showed a weekly performance of 7.66%. On 29 June, Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced an amendment to its distribution and commercialization agreement with Sandoz Inc., a Novartis company, pursuant to which PharmaDerm, the branded dermatology division of Sandoz, distributes and commercializes KERYDIN® (tavaborole) topical solution, 5%, in the United States. Pursuant to the amendment, Sandoz will increase its commercial investment in KERYDIN in 2015, and Anacor will contribute $20 million to Sandoz, primarily focused on consumer-directed commercialization activities.

Iteris, Inc. (NYSEMKT:ITI) shares decreased -0.59% in last trading session and ended the day at $1.69. ITI Gross Margin is 39.00% and its return on assets is -1.60%. Iteris, Inc. (NYSEMKT:ITI) quarterly performance is -8.65%. ON 7 July, Iteris, Inc. (NYSE MKT: ITI), has been awarded a $2.1 million traffic signal synchronization project by the Orange County Transportation Authority (OCTA). The project includes upgrades to traffic signal infrastructure and signal timing improvements along an eight-mile stretch of a major corridor spanning three cities: Santa Ana, Costa Mesa, and Newport Beach.

Leave a Reply

Your email address will not be published. Required fields are marked *